menu search

Bioasis Provides Corporate Update and Announces Suspension of Operations

Bioasis Provides Corporate Update and Announces Suspension of Operations
NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3 ™ platform for delivering therapeutics across the blood-brain barrier (“BBB”) and the treatment of central […] The post Bioasis Provides Corporate Update and Announces Suspension of Operations appea... Read More
Posted: Jun 20 2023, 21:25
Author Name: forextv
Views: 081161

Search within

Pages Search Results: